News headlines about Albemarle Corporation (NYSE:ALB) have been trending somewhat positive recently, according to Accern. The research group identifies negative and positive press coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Albemarle Corporation earned a coverage optimism score of 0.19 on Accern’s scale. Accern also gave press coverage about the specialty chemicals company an impact score of 16 out of 100, indicating that recent press coverage is very unlikely to have an effect on the stock’s share price in the immediate future.
Here are some of the news stories that may have impacted Accern’s analysis:
- Victory Capital Management Inc. Purchases 635 Shares of Albemarle Corporation (ALB) (nolopodrasdejardever.com)
- Zeroing in on Company Shares of Dover Corporation (NYSE:DOV) and Albemarle Corporation (NYSE:ALB) – FLBC News (flbcnews.com)
- Albemarle Corporation (ALB) Given Buy Rating at Royal Bank Of Canada (americanbankingnews.com)
- Stocks Views And Recommendations: Albemarle Corporation (ALB), Aetna Inc. (AET) – AllStockNews (allstocknews.com)
- Albemarle executive named as Charlotte’s CFO of the Year – PR Newswire (press release) (prnewswire.com)
A number of research firms have weighed in on ALB. Zacks Investment Research cut shares of Albemarle Corporation from a “buy” rating to a “hold” rating in a report on Monday, April 24th. Robert W. Baird reiterated an “outperform” rating and issued a $135.00 price objective (up from $125.00) on shares of Albemarle Corporation in a research report on Tuesday. They noted that the move was a valuation call. UBS AG reissued a “neutral” rating and issued a $107.00 target price on shares of Albemarle Corporation in a report on Wednesday, March 22nd. Jefferies Group LLC reissued a “buy” rating and issued a $120.00 target price on shares of Albemarle Corporation in a research note on Tuesday, April 4th. Finally, Piper Jaffray Companies restated an “overweight” rating and issued a $47.00 price target on shares of Albemarle Corporation in a report on Thursday, June 29th. Three investment analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the company. The company presently has an average rating of “Buy” and a consensus target price of $104.80.
Albemarle Corporation (NYSE ALB) opened at 116.86 on Tuesday. The firm has a market cap of $12.94 billion, a price-to-earnings ratio of 28.40 and a beta of 1.58. Albemarle Corporation has a one year low of $75.11 and a one year high of $119.00. The stock’s 50 day moving average price is $110.26 and its 200-day moving average price is $101.62.
Albemarle Corporation (NYSE:ALB) last posted its earnings results on Wednesday, May 3rd. The specialty chemicals company reported $1.05 EPS for the quarter, beating the consensus estimate of $0.95 by $0.10. The company had revenue of $722.06 million for the quarter, compared to the consensus estimate of $678.74 million. Albemarle Corporation had a return on equity of 11.97% and a net margin of 17.02%. Analysts forecast that Albemarle Corporation will post $4.37 earnings per share for the current year.
The business also recently declared a quarterly dividend, which will be paid on Monday, October 2nd. Investors of record on Friday, September 15th will be given a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a yield of 1.10%. The ex-dividend date of this dividend is Thursday, September 14th. Albemarle Corporation’s dividend payout ratio is currently 31.22%.
In other Albemarle Corporation news, Director Douglas L. Maine sold 10,000 shares of the company’s stock in a transaction on Monday, June 19th. The stock was sold at an average price of $107.94, for a total transaction of $1,079,400.00. Following the completion of the sale, the director now directly owns 24,150 shares in the company, valued at $2,606,751. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Chairman Luther C. Iv Kissam sold 50,000 shares of the company’s stock in a transaction on Friday, July 7th. The stock was sold at an average price of $110.08, for a total value of $5,504,000.00. Following the sale, the chairman now owns 252,917 shares of the company’s stock, valued at $27,841,103.36. The disclosure for this sale can be found here. Insiders have sold 105,000 shares of company stock worth $11,499,850 in the last three months. 0.74% of the stock is currently owned by company insiders.
COPYRIGHT VIOLATION WARNING: This piece was originally posted by Sports Perspectives and is the sole property of of Sports Perspectives. If you are reading this piece on another website, it was illegally copied and reposted in violation of US & international copyright laws. The legal version of this piece can be read at https://sportsperspectives.com/2017/07/18/somewhat-favorable-press-coverage-very-unlikely-to-impact-albemarle-corporation-nysealb-stock-price-updated.html.
About Albemarle Corporation
Albemarle Corporation is a global developer, manufacturer and marketer of highly-engineered specialty chemicals. The Company operates through three segments: Lithium and Advanced Materials, Bromine Specialties and Refining Solutions. Lithium and Advanced Materials segment consist of two product categories: Lithium and Performance Catalyst Solutions.
Receive News & Ratings for Albemarle Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle Corporation and related companies with MarketBeat.com's FREE daily email newsletter.